B
JAZZ icon

Barings’s Jazz Pharmaceuticals JAZZ Stock Holding History

Barings’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,668
Closed -$266K – 626
2020
Q2 		$266K Hold
2,668
– – 0.01% 470
2020
Q1 		$266K Buy
2,668
+81
+3% +$10.5K 0.01% 470
2019
Q4 		$385K Sell
2,587
-2,313
-47% -$315K 0.01% 496
2019
Q3 		$628K Buy
4,900
+1,340
+38% +$180K 0.01% 452
2019
Q2 		$508K Sell
3,560
-10,430
-75% -$1.4M 0.01% 498
2019
Q1 		$2M Buy
13,990
+8,380
+149% +$1.09M 0.05% 278
2018
Q4 		$695K Hold
5,610
– – 0.01% 443
2018
Q3 		$943K Hold
5,610
– – 0.01% 502
2018
Q2 		$967K Buy
+5,610
New +$917K 0.01% 517
2015
Q4 		– Sell
-6,670
Closed -$886K – 944
2015
Q3 		$886K Buy
6,670
+4,990
+297% +$859K 0.02% 488
2015
Q2 		$296K Buy
+1,680
New +$302K 0.01% 827
2014
Q4 		– Sell
-6,030
Closed -$968K – 945
2014
Q3 		$968K Sell
6,030
-210
-3% -$32.3K 0.02% 476
2014
Q2 		$917K Buy
6,240
+1,370
+28% +$190K 0.03% 529
2014
Q1 		$675K Sell
4,870
-3,100
-39% -$467K 0.02% 567
2013
Q4 		$1.01M Sell
7,970
-3,330
-29% -$345K 0.04% 416
2013
Q3 		$1.04M Buy
11,300
+5,300
+88% +$428K 0.04% 411
2013
Q2 		$412K Buy
+6,000
New +$367K 0.02% 645

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Barings's JAZZ Position: Q3 2020 in Review

Barings sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2020, closing a stake of 2,668 shares — an estimated $266K sold.

Barings first reported a position in JAZZ in Q2 2013 and held it in 17 quarters. The position peaked at $2M in Q1 2019. 389 funds tracked by Wall St. Rank hold JAZZ as of Q3 2020.

  • Barings reported no remaining Jazz Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Barings sold 2,668 Jazz Pharmaceuticals shares in Q3 2020, an estimated $266K.
  • Barings first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Barings's Jazz Pharmaceuticals position peaked at $2M in Q1 2019.
  • 389 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2020.

Based on Barings's 13F filing for Q3 2020, filed 12 Nov 2020.